Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Impax Laboratories Inc (NASDAQ:IPXL)

12.95
Delayed Data
As of Dec 06
 -0.45 / -3.36%
Today’s Change
12.45
Today|||52-Week Range
44.86
-69.71%
Year-to-Date

Today’s Trading

Previous close13.40
Today’s open13.50
Day’s range12.75 - 13.50
Volume2,386,579
Average volume (3 months)1,220,757
Market cap$990.0M
Dividend yield--
Data as of 12/06/2016

Growth & Valuation

Earnings growth (last year)-33.33%
Earnings growth (this year)-18.21%
Earnings growth (next 5 years)+5.00%
Revenue growth (last year)+44.36%
P/E ratioNM
Price/Sales3.58
Price/Book0.92

Competitors

 Today’s
change
Today’s
% change
SGYPSynergy Pharmaceutic...+0.13+2.37%
ACORAcorda Therapeutics ...+0.45+2.12%
AMPHAmphastar Pharmaceut...+0.11+0.53%
MGNXMacroGenics Inc+1.16+4.28%
Data as of 3:59pm ET, 12/06/2016

Financials

Next reporting dateFebruary 28, 2017
EPS forecast (this quarter)$0.18
Annual revenue (last year)$860.5M
Annual profit (last year)$39.0M
Net profit margin4.53%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Generic
President, Chief Executive Officer &
Director
George Frederick Wilkinson
Senior Vice President-
Global Operations
Andrew Schaschl
Corporate headquarters
Hayward, California

Forecasts


Search for Jobs